214 results on '"J. Pahnke"'
Search Results
2. Abstracts of the 33rd International Austrian Winter Symposium
- Author
-
K. Binzel, A. Adelaja, C. L. Wright, D. Scharre, J. Zhang, M. V. Knopp, E. J. Teoh, D. Bottomley, A. Scarsbrook, H. Payne, A. Afaq, J. Bomanji, N. van As, S. Chua, P. Hoskin, A. Chambers, G. J. Cook, V. S. Warbey, A. Chau, P. Ward, M. P. Miller, D. J. Stevens, L. Wilson, F. V. Gleeson, K. Scheidhauer, C. Seidl, M. Autenrieth, F. Bruchertseifer, C. Apostolidis, F. Kurtz, T. Horn, C. Pfob, M. Schwaiger, J. Gschwend, C. D’Alessandria, A. Morgenstern, C. Uprimny, A. Kroiss, C. Decristoforo, E. von Guggenberg, B. Nilica, W. Horninger, I. Virgolini, S. Rasul, N. Poetsch, A. Woehrer, M. Preusser, M. Mitterhauser, W. Wadsak, G. Widhalm, M. Mischkulnig, M. Hacker, T. Traub-Weidinger, E. J. Wuthrick, E. D. Miller, P. Maniawski, Sebastijan Rep, Marko Hocevar, Janja Vaupotic, Urban Zdesar, Katja Zaletel, Luka Lezaic, S. Mairinger, Thomas Filip, M. Sauberer, S. Flunkert, T. Wanek, J. Stanek, N. Okamura, O. Langer, C. Kuntner, M. C. Fornito, R. Balzano, V. Di Martino, S. Cacciaguerra, G. Russo, D. Seifert, M. Kleinova, A. Cepa, J. Ralis, P. Hanc, O. Lebeda, M. Mosa, S. Vandenberghe, E. Mikhaylova, D. Borys, V. Viswanath, M. Stockhoff, N. Efthimiou, P. Caribe, R. Van Holen, J. S. Karp, P. M. Haller, C. Farhan, E. Piackova, B. Jäger, P. Knoll, A. Kiss, B. K. Podesser, J. Wojta, K. Huber, S. Mirzaei, A. Traxl, K. Komposch, Elisabeth Glitzner, M. Sibilia, M. Russello, S. Sorko, H. J. Gallowitsch, S. Kohlfuerst, S. Matschnig, M. Rieser, M. Sorschag, P. Lind, L. Ležaič, S. Rep, J. Žibert, N. Frelih, S. Šuštar, R. P. Baum, T. Langbein, A. Singh, M. Shahinfar, C. Schuchardt, G. F. Volk, H. R. Kulkarni, G. V. Di Martino, W. H. Thomson, M. Kudlacek, M. Karik, H. Rieger, W. Pokieser, K. Glaser, V. Petz, C. Tugendsam, W. Buchinger, B. Schmoll-Hauer, I. P. Schenk, K. Rudolph, M. Krebs, G. Zettinig, V. Zoufal, M. Krohn, T. Filip, J. Pahnke, F. Weitzer, B. Pernthaler, S. Salamon, R. Aigner, P. Koranda, L. Henzlová, M. Kamínek, Mo. Váchalová, P. Bachleda, D. Summer, J. Garousi, M. Oroujeni, B. Mitran, K. G. Andersson, A. Vorobyeva, J.n Löfblom, A. Orlova, V. Tolmachev, P. Kaeopookum, T. Orasch, B. Lechner, M. Petrik, Z. Novy, C. Rangger, and H. Haas
- Subjects
Medical physics. Medical radiology. Nuclear medicine ,R895-920 - Published
- 2018
- Full Text
- View/download PDF
3. 32nd International Austrian Winter Symposium
- Author
-
W Langsteger, A Rezaee, W Loidl, HS Geinitz, F Fitz, M Steinmair, G Broinger, L Pallwien-Prettner, M Beheshti, L Imamovic, G Rendl, D Hackl, O Tsybrovsky, K Emmanuel, F Moinfar, C Pirich, A Bytyqi, G Karanikas, M Mayerhöfer, O Koperek, B Niederle, M Hartenbach, T Beyer, K Herrmann, J Czernin, I Rausch, P Rust, MD DiFranco, M Lassen, A Stadlbauer, ME Mayerhöfer, M Hacker, K Binzel, R Magnussen, W Wei, MU Knopp, DC Flanigan, C Kaeding, MV Knopp, A Leisser, M Nejabat, G Kramer, M Krainer, A Haug, Wencke Lehnert, Karl Schmidt, Sharok Kimiaei, Marcus Bronzel, Andreas Kluge, CL Wright, J Zhang, Evan Wuthrick, Piotr Maniawski, M Blaickner, E Rados, A Huber, M Dulovits, H Kulkarni, S Wiessalla, C Schuchardt, RP Baum, B Knäusl, D Georg, M Bauer, B Wulkersdorfer, W Wadsak, C Philippe, H Haslacher, M Zeitlinger, O Langer, M Feldmann, R Karch, MJ Koepp, M-C Asselin, E Pataraia, M Zeilinger, M Dumanic, F Pichler, J Pilz, M Mitterhauser, L Nics, B Steiner, A Traxl, Thomas Wanek, Kushtrim Kryeziu, Severin Mairinger, Johann Stanek, Walter Berger, Claudia Kuntner, Oliver Langer, S Mairinger, T Wanek, M Krohn, J Stanek, T Filip, M Sauberer, C Kuntner, J Pahnke, D Svatunek, C Denk, M Wilkovitsch, C Kuntner-Hannes, J Fröhlich, H Mikula, T Balber, J Singer, J Fazekas, C Rami-Mark, N Berroterán-Infante, E Jensen-Jarolim, H Viernstein, B Sohr, S Pfaff, E Halilbasic, M Visentin, B Stieger, M Trauner, P Lam, M Aistleitner, R Eichinger, C Artner, H Eidherr, C Vraka, H Kvaternik, R Müller, D Hausberger, C Zink, RM Aigner, U Cossío, M Asensio, A Montes, S Akhtar, Y te Welscher, R van Nostrum, V Gómez-Vallejo, J Llop, F VandeVyver, T Barclay, N Lippens, M Troch, L Hehenwarter, B Egger, J Holzmannhofer, M Rodrigues-Radischat, N Pötsch, D Wilhelm, M Weber, J Furtner, A Wöhrer, T Traub-Weidinger, T Cassou-Mounat, S Balogova, V Nataf, M Calzada, V Huchet, K Kerrou, J-Y Devaux, M Mohty, L Garderet, J-N Talbot, S Stanzel, G Pregartner, T Schwarz, V Bjelic-Radisic, B Liegl-Atzwanger, R Aigner, F Quehenberger, A Koljević Marković, Milica Janković, V Miler Jerković, M Paskaš, G Pupić, R Džodić, D Popović, MC Fornito, D Familiari, P Koranda, H Polzerová, I Metelková, L Henzlová, R Formánek, E Buriánková, M Kamínek, WH Thomson, C Lewis, J O’Brien, G James, A Notghi, H Huber, I Stelzmüller, R Wunn, M Mandl, F Fellner, B Lamprecht, M Gabriel, G Leonardi, J Hudzietzová, J Sabol, and M Fülöp
- Subjects
Prostate cancer ,medicine.medical_specialty ,business.industry ,General surgery ,medicine ,MEDLINE ,Radiology, Nuclear Medicine and imaging ,urologic and male genital diseases ,medicine.disease ,business ,Meeting Abstracts ,Cardiac imaging ,3. Good health - Abstract
Table of contents A1 68Ga-PSMA PET/CT in staging and restaging of Prostate Cancer Patients: comparative study with 18F-Choline PET/CT W Langsteger, A Rezaee, W Loidl, HS Geinitz, F Fitz, M Steinmair, G Broinger, L Pallwien-Prettner, M Beheshti A2 F18 Choline PET – CT: an accurate diagnostic tool for the detection of parathyroid adenoma? L Imamovic, M Beheshti, G Rendl, D Hackl, O Tsybrovsky, M Steinmair, K Emmanuel, F Moinfar, C Pirich, W Langsteger A3 [18F]Fluoro-DOPA-PET/CT in the primary diagnosis of medullary thyroid carcinoma A Bytyqi, G Karanikas, M Mayerhöfer, O Koperek, B Niederle, M Hartenbach A4 Variations of clinical PET/MR operations: An international survey on the clinical utilization of PET/MRI T Beyer, K Herrmann, J Czernin A5 Standard Dixon-based attenuation correction in combined PET/MRI: Reproducibility and the possibility of Lean body mass estimation I Rausch, P Rust, MD DiFranco, M Lassen, A Stadlbauer, ME Mayerhöfer, M Hartenbach, M Hacker, T Beyer A6 High resolution digital FDG PET/MRI imaging for assessment of ACL graft viability K Binzel, R Magnussen, W Wei, MU Knopp, DC Flanigan, C Kaeding, MV Knopp A7 Using pre-existing hematotoxicity as predictor for severe side effects and number of treatment cycles of Xofigo therapy A Leisser, M Nejabat, M Hartenbach, G Kramer, M Krainer, M Hacker, A Haug A8 QDOSE – comprehensive software solution for internal dose assessment Wencke Lehnert, Karl Schmidt, Sharok Kimiaei, Marcus Bronzel, Andreas Kluge A9 Clinical impact of Time-of-Flight on next-generation digital PET imaging of Yttrium-90 radioactivity following liver radioembolization CL Wright, K Binzel, J Zhang, Evan Wuthrick, Piotr Maniawski, MV Knopp A10 Snakes in patients! Lessons learned from programming active contours for automated organ segmentation M Blaickner, E Rados, A Huber, M Dulovits, H Kulkarni, S Wiessalla, C Schuchardt, RP Baum, B Knäusl, D Georg A11 Influence of a genetic polymorphism on brain uptake of the dual ABCB1/ABCG2 substrate [11C]tariquidar M Bauer, B Wulkersdorfer, W Wadsak, C Philippe, H Haslacher, M Zeitlinger, O Langer A12 Outcome prediction of temporal lobe epilepsy surgery from P-glycoprotein activity. Pooled analysis of (R)-[11C]-verapamil PET data from two European centres M Bauer, M Feldmann, R Karch, W Wadsak, M Zeitlinger, MJ Koepp, M-C Asselin, E Pataraia, O Langer A13 In-vitro and in-vivo characterization of [18F]FE@SNAP and derivatives for the visualization of the melanin concentrating hormone receptor 1 M Zeilinger, C Philippe, M Dumanic, F Pichler, J Pilz, M Hacker, W Wadsak, M Mitterhauser A14 Reducing time in quality control leads to higher specific radioactivity of short-lived radiotracers L Nics, B Steiner, M Hacker, M Mitterhauser, W Wadsak A15 In vitro 11C-erlotinib binding experiments in cancer cell lines with epidermal growth factor receptor mutations A Traxl, Thomas Wanek, Kushtrim Kryeziu, Severin Mairinger, Johann Stanek, Walter Berger, Claudia Kuntner, Oliver Langer A16 7-[11C]methyl-6-bromopurine, a PET tracer to measure brain Mrp1 function: radiosynthesis and first PET evaluation in mice S Mairinger, T Wanek, A Traxl, M Krohn, J Stanek, T Filip, M Sauberer, C Kuntner, J Pahnke, O Langer A17 18F labeled azidoglucose derivatives as “click” agents for pretargeted PET imaging D Svatunek, C Denk, M Wilkovitsch, T Wanek, T Filip, C Kuntner-Hannes, J Fröhlich, H Mikula A18 Bioorthogonal tools for PET imaging: development of radiolabeled 1,2,4,5-Tetrazines C Denk, D Svatunek, T Wanek, S Mairinger, J Stanek, T Filip, J Fröhlich, H Mikula, C Kuntner-Hannes A19 Preclinical evaluation of [18F]FE@SUPPY- a new PET-tracer for oncology T Balber, J Singer, J Fazekas, C Rami-Mark, N Berroterán-Infante, E Jensen-Jarolim, W Wadsak, M Hacker, H Viernstein, M Mitterhauser A20 Investigation of Small [18F]-Fluoroalkylazides for Rapid Radiolabeling and In Vivo Click Chemistry C Denk, D Svatunek, B Sohr, H Mikula, J Fröhlich, T Wanek, C Kuntner-Hannes, T Filip A21 Microfluidic 68Ga-radiolabeling of PSMA-HBED-CC using a flow-through reactor S Pfaff, C Philippe, M Mitterhauser, M Hartenbach, M Hacker, W Wadsak A22 Influence of 24-nor-ursodeoxycholic acid on hepatic disposition of [18F]ciprofloxacin measured with positron emission tomography T Wanek, E Halilbasic, M Visentin, S Mairinger, B Stieger, C Kuntner, M Trauner, O Langer A23 Automated 18F-flumazenil production using chemically resistant disposable cassettes P Lam, M Aistleitner, R Eichinger, C Artner A24 Similarities and differences in the synthesis and quality control of 177Lu-DOTA-TATE, 177Lu -HA-DOTA-TATE and 177Lu-DOTA-PSMA (PSMA-617) H Eidherr, C Vraka, A Haug, M Mitterhauser, L Nics, M Hartenbach, M Hacker, W Wadsak A25 68Ga- and 177Lu-labelling of PSMA-617 H Kvaternik, R Müller, D Hausberger, C Zink, RM Aigner A26 Radiolabelling of liposomes with 67Ga and biodistribution studies after administration by an aerosol inhalation system U Cossío, M Asensio, A Montes, S Akhtar, Y te Welscher, R van Nostrum, V Gómez-Vallejo, J Llop A27 Fully automated quantification of DaTscan SPECT: Integration of age and gender differences F VandeVyver, T Barclay, N Lippens, M Troch A28 Lesion-to-background ratio in co-registered 18F-FET PET/MR imaging – is it a valuable tool to differentiate between low grade and high grade brain tumor? L Hehenwarter, B Egger, J Holzmannhofer, M Rodrigues-Radischat, C Pirich A29 [11C]-methionine PET in gliomas - a retrospective data analysis of 166 patients N Pötsch, I Rausch, D Wilhelm, M Weber, J Furtner, G Karanikas, A Wöhrer, M Mitterhauser, M Hacker, T Traub-Weidinger A30 18F-Fluorocholine versus 18F-Fluorodeoxyglucose for PET/CT imaging in patients with relapsed or progressive multiple myeloma: a pilot study T Cassou-Mounat, S Balogova, V Nataf, M Calzada, V Huchet, K Kerrou, J-Y Devaux, M Mohty, L Garderet, J-N Talbot A31 Prognostic benefit of additional SPECT/CT in sentinel lymph node mapping of breast cancer patients S Stanzel, G Pregartner, T Schwarz, V Bjelic-Radisic, B Liegl-Atzwanger, R Aigner A32 Evaluation of diagnostic value of TOF-18F-FDG PET/CT in patients with suspected pancreatic cancer S Stanzel, F Quehenberger, RM Aigner A33 New quantification method for diagnosis of primary hyperpatahyroidism lesions and differential diagnosis vs thyropid nodular disease in dynamic scintigraphy A Koljević Marković, Milica Janković, V Miler Jerković, M Paskaš, G Pupić, R Džodić, D Popović A34 A rare case of diffuse pancreatic involvement in patient with merkel cell carcinoma detected by 18F-FDG MC Fornito, D Familiari A35 TSH-stimulated 18F-FDG PET/CT in the diagnosis of recurrent/metastatic radioiodine-negative differentiated thyroid carcinomas in patients with various thyroglobuline levels P Koranda, H Polzerová, I Metelková, L Henzlová, R Formánek, E Buriánková, M Kamínek A36 Breast Dose from lactation following I131 treatment WH Thomson, C Lewis A37 A new concept for performing SeHCAT studies with the gamma camera WH Thomson, J O’Brien, G James, A Notghi A38 Whole body F-18-FDG-PET and tuberculosis: sensitivity compared to x-ray-CT H Huber, I Stelzmüller, R Wunn, M Mandl, F Fellner, B Lamprecht, M Gabriel A39 Emerging role 18F-FDG PET-CT in the diagnosis and follow-up of the infection in heartware ventricular assist system (HVAD) MC Fornito, G Leonardi A40 Validation of Poisson resampling software WH Thomson, J O’Brien, G James A41 Protection of PET nuclear medicine personnel: problems in satisfying dose limit requirements J Hudzietzová, J Sabol, M Fülöp
- Published
- 2016
4. Strukturpathologie des Skelettmuskels
- Author
-
J. Buchmann and J. Pahnke
- Published
- 2016
5. MOF@PolyHIPEs
- Author
-
M. G. Schwab, I. Senkovska, M. Rose, M. Koch, J. Pahnke, G. Jonschker, and S. Kaskel
- Subjects
General Materials Science ,Condensed Matter Physics - Published
- 2008
6. Expression of stromelysin-1 (MMP-3), gelatinase B (MMP-9), and plasminogen activator system during fetal calvarial development
- Author
-
J Pahnke, Alexander Marx, and P Zeitler
- Subjects
medicine.medical_specialty ,Histology ,Plasmin ,Connective tissue ,Receptors, Cell Surface ,Matrix metalloproteinase ,Receptors, Urokinase Plasminogen Activator ,Pathology and Forensic Medicine ,Extracellular matrix ,Internal medicine ,medicine ,Humans ,Fibrinolysin ,Urokinase ,biology ,Skull ,General Medicine ,Urokinase-Type Plasminogen Activator ,Extracellular Matrix ,Cell biology ,Fibronectin ,Urokinase receptor ,medicine.anatomical_structure ,Endocrinology ,Matrix Metalloproteinase 9 ,biology.protein ,Matrix Metalloproteinase 3 ,Plasminogen activator ,medicine.drug - Abstract
Aims: To investigate whether degrading proteases can be found in patent calvarial sutures. Sutural growth and fusion means replacement of the sutural connective tissue, rich in fibronectin and collagen type V, by expanding calvarial bone. Proliferation of one tissue into the border area of another implies the presence of enzymes able to degrade extracellular matrix (ECM). An important family of proteases is the matrix metalloproteinases (MMPs), as is the plasminogen/plasmin system. Methods and results: Expression of two MMPs with substrate specifity for fibronectin and collagen type V and of the plasminogen activator system was studied by immunohistochemistry in samples of human fetal calvariae (age range weeks 19–35 of gestation). In all cases, intense staining for MMPs, urokinase, and urokinase receptor was found in the sutural connective tissue and along the outer and inner borders of calvarial bone. Conclusions: Our findings suggest that degradation of sutural connective tissue takes place during sutural growth. This might facilitate proliferation of calvarial bone. Recently, it was shown that an important regulatory mechanism of sutural growth is apoptosis of osteoblasts in the osteogenic front. Intact fibronectin is known to prevent apoptosis of proliferating osteoblasts while fibronectin degradation induces their apoptosis.
- Published
- 2004
7. Morphologie, Funktion und Klinik der Tuba Eustachii
- Author
-
J. Pahnke
- Subjects
Otorhinolaryngology ,business.industry ,Medicine ,business - Published
- 2000
8. Zervikale Lymphknotenmetastasen bei unbekanntem Primärtumor
- Author
-
K. Schwager, Leo Pfreundner, Michael Flentje, and J. Pahnke
- Subjects
Gynecology ,medicine.medical_specialty ,Oncology ,business.industry ,Medicine ,Hematology ,business - Published
- 1997
9. Systematik der zervikalen Lymphknotenmetastasierung von Larynx- und Hypopharynxkarzinomen - Eine klinisch-computertomographische Studie unter besonderer Berücksichtigung der Ausdehnung des Primärtumors
- Author
-
M. Schindel, L. Pfreundner, A. Desing, and J. Pahnke
- Subjects
Larynx ,Pathology ,medicine.medical_specialty ,business.industry ,Cancer ,medicine.disease ,Primary tumor ,Metastasis ,Hypopharyngeal Carcinoma ,medicine.anatomical_structure ,Lymphatic system ,Otorhinolaryngology ,otorhinolaryngologic diseases ,Carcinoma ,medicine ,business ,Lymph node - Abstract
PURPOSE To assess the incidence and patterns of cervical lymph node metastases in laryngeal and hypopharyngeal carcinomas according to the location, extension, and relation of the primary tumor to the parapharyngeal compartments and tissues arising from different embryological structures as branchial arches and somites. PATIENTS AND METHODS The findings of clinical and CT examinations of 230 patients with histological evidence of laryngeal and hypopharyngeal carcinoma (44 T1-, 33 T2-, 41 T3-, 112 T4-carcinomas with lymph node involvement in 116 cases) were evaluated retrospectively. Local tumor spread and relation of the primary to the parapharyngeal compartments and to tissues arising from different embryological structures such as branchial arches and somites were analysed and related to cervical lymph node involvement. RESULTS The pattern of cervical lymph node involvement depends upon location and extension of the primary tumor in the adjacent tissues of the larynx and hypopharynx. The density of the lymphatic vessels in these areas determines the likelihood of lymph node involvement. The frequency of NO cases in carcinomas strictly located in the vocal cord (n = 31) was 100%; in the glottic-supraglottic, supraglottic, and transglottic cancer (n = 106) 85%; in larynx-hypopharynx carcinomas (n = 54) 26%; in hypopharynx carcinomas (n = 12) 17%; and in larynx-hypo-oropharynx carcinomas (n = 46) 9%. Tumors in tissues arising from branchial arches 4, 5, and 6 are glottic-supraglottic, transglottic laryngeal, and laryngeal-hypopharyngeal carcinomas. Metastases of these tumors were frequently found in the jugular lymph node chains, particularly if the developed tissue of the "primitive glottis" was invaded by the primary. Upper jugular nodes ipsilateral to a supraglottic or hypopharyngeal primary were usually involved. The frequency of metastases in the jugular lymph node chains decreased in craniocaudal direction. If the tumor invaded the posterior wall of the hypopharynx or tissues.
- Published
- 1996
10. Analyse der zervikalen Lymphknotenmetastasierung von Oropharynxkarzinomen in Abhängigkeit von der Ausdehnung des Primärtumors
- Author
-
L. Pfreundner, J. Pahnke, and S. Wameling
- Subjects
Larynx ,Pathology ,medicine.medical_specialty ,business.industry ,Branchial arch ,Anatomy ,medicine.disease ,Metastasis ,medicine.anatomical_structure ,Lymphatic system ,Otorhinolaryngology ,Oropharyngeal Carcinoma ,medicine ,Carcinoma ,Lymph ,business ,Lymph node - Abstract
PURPOSE To assess the incidence and patterns of cervical lymph node involvement according to the location and the relation of the primary tumour to the parapharyngeal fasciae, compartments and tissues arising from different branchial arches. PATIENTS AND METHODS The findings of clinical and CT examinations of 143 patients with histological evidence of oropharyngeal carcinoma were evaluated retrospectively. Local tumour spread, relation of the primary to the parapharyngeal fasciae, compartments and to the borders of tissues arising from different branchial arches were analysed and related to cervical lymph node involvement. RESULTS Lymph drainage of the oropharynx and neighbouring neck regions is determined by the embryological development of the branchial arches and somites. Oropharyngeal carcinomas are tumours arising from tissues of the 2nd and 3rd branchial arches. The lymph of these tissues is collected by the vessels of the jugular neck node chains. If tumour invades tissues arising from the 1st branchial arch (structures of the oral cavity and floor of the mouth) tumour spreads into the ipsilateral lymphatic vessels arising from the 1st branchial arch and the submaxillary lymph nodes. If tumor invades tissues arising from occipital and cervical somites (posterior wall of the nasopharynx, retropharyngeal compartment and recessus submuscularis) metastases in the retropharyngeal and spinal-accessorial lymph nodes may appear. Regarding the tumour invasion of the subdistricts of the oropharynx totally different tumours were found. Tumour invasion of neighbouring structures was documented for the nasopharynx in 15%, for oral cavity and the floor of the mouth in 34%, the larynx in 24% and the hypopharynx in 22% of the cases. From these different patterns of local tumour spread different patterns of lymph node involvement resulted. Nodal involvement was found in 71%. In all these cases metastases in the ipsilateral upper jugular lymph nodes were present. The frequency of metastases in the jugular lymph node chains decreased in cranio-caudad direction (upper jugular group 100%, middle 18%, lower jugular group 5%). The frequency of bilateral jugular lymph node involvement (25%) increased in the some measure as the tumour approached the midline or crossed it. CONCLUSIONS Knowledge of regular patterns of spread of oropharyngeal carcinoma is important for treatment procedures, especially for 3-dimensional radiotherapy.
- Published
- 1996
11. High-resolutation magnetic resonance imaging of the endolymphatic duct and sac
- Author
-
Michael Deimling, H. P. Hollenbach, J. Pahnke, W. J. Huk, and K. E. W. Eberhardt
- Subjects
Adult ,Male ,Radiological and Ultrasound Technology ,medicine.diagnostic_test ,business.industry ,Biophysics ,Healthy subjects ,High resolution ,Magnetic resonance imaging ,Anatomy ,Magnetic Resonance Imaging ,Endolymphatic sac ,Endolymphatic duct ,medicine.anatomical_structure ,Maximum intensity projection ,Temporal bone ,medicine ,Humans ,Female ,Radiology, Nuclear Medicine and imaging ,Inner ear ,Endolymphatic Sac ,Endolymphatic Duct ,business - Abstract
An anatomical study was carried out to determine the extent to which magnetic resonance imaging (MRI) could delineate inner ear structures. Anatomical preparations of human petrous temporal bone were examined and compared with the results of MRI in 20 healthy subjects to see whether the structures of the inner ear could be visualized. Imaging of the subjects was carried out in a 1.0-T MRI scanner (Siemens Magnetom Impact). Two strongly T2*-weighted sequences were used: a 3D-PSIF sequence and a 3D-CISS sequence. The 3D data sets were postprocessed using a Maximum Intensity Projection (MIP) program. Our investigations show that it is possible to obtain accurate visualization of structures with a diameter of under 1 mm. In all 20 subjects it was possible to identify both the endolymphatic duct and the endolymphatic sac.
- Published
- 1995
12. Orthopädische Erkrankungen und Tinnitus
- Author
-
S.W. Wicke-Wittenius, J. Pahnke, E. Hipp, H.-J. Wassmundt, and J.S. Träger
- Subjects
Otorhinolaryngology - Abstract
Klinische Erfahrungen und Beobachtungen lassen vermuten, dass der AuslOser fUr Tinnitus und HOrstOrungen auch im Bereich der HalswirbelsAule zu suchen ist. In der vorliegenden
- Published
- 1995
13. NO-Messung – Therapiesteuerung bei Asthma am Beispiel einer Kasuistik
- Author
-
J Pahnke
- Subjects
Pulmonary and Respiratory Medicine - Published
- 2012
14. [Involvement of CNS in leukaemia and lymphomas--CSF meningeosis and immunocytochemical phenotyping]
- Author
-
R, Lehmitz and J, Pahnke
- Subjects
Leukemia ,Phenotype ,Lymphoma ,Central Nervous System Diseases ,Humans ,World Health Organization ,Immunohistochemistry - Abstract
The detection of tumour cells in the cerebrospinal fluid (CSF) of leukaemia and lymphoma patients is a challenge for CSF cytological investigation. Nevertheless, it is generally possible to confirm the involvement of the central nervous system (CNS) by conventional microscopic detection of tumour cells. Immunocytochemical staining techniques are a valuable complement of conventional cytology. Immunocytochemical cell phenotyping is indicated for identification of atypical cells in patients with suspected primary CNS lymphoma or malignant haematological disease.
- Published
- 2009
15. [The role of blood-brain barrier in the pathogenesis of Alzheimer dementia--implications for immunological therapies for plaque dissolution]
- Author
-
J, Pahnke, M, Krohn, and K, Scheffler
- Subjects
Neurons ,Amyloid beta-Peptides ,Alzheimer Disease ,Blood-Brain Barrier ,Humans ,ATP-Binding Cassette Transporters ,Plaque, Amyloid ,Immunotherapy - Abstract
Alzheimer's disease (AD) is a devastating neurodegenerative disorder affecting more than 27 million people worldwide and leading to severe social-economic problems. One characteristic hallmark of AD--the amyloid plaques--are still being discussed to be one important triggering factor. However, current animal and autopsy studies refer to soluble and highly toxic A block oligomers as the deadly agent for the neurons. Current therapies mainly rely on the abatement of symptoms without antagonizing the etiology of the disease. Potential new approaches address reduced production, increased degradation and/or evacuation of toxic A block peptides from the brain. Among others one important group of target-proteins are the ABC transporters of the blood-brain barrier which contribute importantly to the detoxification of the brain. Changes of specific transport functions evoke important alterations for the known pathogenesis and future therapies of AD, especially approaches that target plaque dissolution and plaque reduction.
- Published
- 2009
16. Anatomie der Schädelbasis
- Author
-
J. Pahnke
- Subjects
Radiology, Nuclear Medicine and imaging - Published
- 2006
17. Expression of multidrug transporters in dysembryoplastic neuroepithelial tumors causing intractable epilepsy
- Author
-
S, Vogelgesang, C, Kunert-Keil, I, Cascorbi, I, Mosyagin, E, Schröder, U, Runge, G, Jedlitschky, H K, Kroemer, J, Oertel, M R, Gaab, J, Pahnke, L C, Walker, and R W, Warzok
- Subjects
Adult ,Intracranial Arteriovenous Malformations ,Male ,Epilepsy ,Polymorphism, Genetic ,Adolescent ,Brain Neoplasms ,Reverse Transcriptase Polymerase Chain Reaction ,Drug Resistance ,Endothelial Cells ,Middle Aged ,Immunohistochemistry ,Neoplasms, Neuroepithelial ,Image Processing, Computer-Assisted ,Humans ,Female ,Multidrug Resistance-Associated Proteins ,Child - Abstract
Dysembryoplastic neuroepithelial tumors (DNT) are relatively benign brain lesions that often cause medically intractable epilepsy. There is mounting evidence that multidrug transporters such as P-glycoprotein (P-gp) or multidrug resistance-associated proteins (MRP) play an important role in the development of resistance to antiepileptic drugs (AED).In the present study, we examined the expression of several multidrug transporters in 14 cases of DNT. The peritumoral brain tissue as well as 9 cases of arteriovenous malformations (AVM) served as controls. P-gp, MRP2, MRP5 and breast cancer resistance protein (BCRP) expression was evaluated qualitatively and quantitatively using immunohistochemistry.All transporters were overexpressed quantitatively in DNT, but each revealed a different labeling pattern. P-gp and BCRP were predominantly located in the endothelium of brain vessels. MRP5 was detected primarily in endothelial cells, but notably also in neurons. The expression of P-gp, MRP2 and MRP5 was low in AVM, whereas BCRP demonstrated strong staining. Examination of MDR1 gene polymorphisms revealed no correlation with P-gp expression whereas the MRP2 exon 10 G1249A polymorphism was associated with different MRP2 labelling.Our results show that multidrug transporters are overexpressed in DNT. This finding supports the view that several of these transport proteins may play an important role in the mechanisms of drug resistance in epileptic brain tissue.
- Published
- 2004
18. Combined biotin-terpyridine systems : a new versatile bridge between biology, polymer science and metallo-supramolecular chemistry
- Author
-
J Pahnke, Ulrich S. Schubert, H Harald Hofmeier, Christian H. Weidl, and Chemical Engineering and Chemistry
- Subjects
chemistry.chemical_classification ,Streptavidin ,Bridged-Ring Compounds ,Polymers and Plastics ,biology ,Polymers ,Pyridines ,Supramolecular chemistry ,technology, industry, and agriculture ,Biotin ,Bioengineering ,Polymer ,Combinatorial chemistry ,Biomaterials ,chemistry.chemical_compound ,End-group ,chemistry ,Materials Chemistry ,biology.protein ,Organometallic Compounds ,Organic chemistry ,Chelation ,Terpyridine ,Avidin - Abstract
Biotin, a well-known binding unit for the proteins avidin and streptavidin, was combined with the chelating ligand terpyridine via polymeric and nonpolymeric spacers. An omega-amino-functionalized terpyridyl-poly(ethylene glycol) was prepared and utilized for complex formation with iron(II), nickel(II), and ruthenium(II) ions. The biocompatibility of the complex formation was investigated in aqueous media. Moreover, biotin was functionalized with a methoxy-poly(ethylene glycol) as a model system. The compounds were characterized by UV/vis and NMR spectroscopy as well as MALDI-TOF mass spectrometry. The systems represent a new combination of strong noncovalent binding units from both biology and synthetic supramolecular chemistry.
- Published
- 2004
19. Activated microglia do not mediate the early deposition of Abeta in carriers of the apolipoprotein Eepsilon4 allele
- Author
-
S, Vogelgesang, E, Schroeder, L C, Walker, J, Pahnke, A, Naubereit, R, Walther, D, Stausske, and R W, Warzok
- Subjects
Aged, 80 and over ,Male ,Amyloid beta-Peptides ,Genotype ,Apolipoprotein E4 ,Age Factors ,Brain ,Cell Count ,Plaque, Amyloid ,Middle Aged ,Apolipoproteins E ,Sex Factors ,Humans ,Female ,Microglia ,Alleles ,Aged - Abstract
Activated microglia are a prominent component of the senile plaques in end-stage Alzheimer's disease, but whether microglia contribute to the initiation of the lesions remains unknown. In a previous postmortem study of non-demented elderly cases, we found that amyloidogenesis is advanced by at least 10 years in carriers of the apoEepsilon4 allele. To determine whether microglia are involved in the initial stages of beta-amyloid pathogenesis and whether apoE genotype influences microglial activation, we quantified HLA-DR-immunoreactive microglia in the medial temporal lobe of 229 non-demented humans of various APOE genotypes who had died between 50 and 91 years of age. Our results show that the number of HLA-DR-immunoreactive microglia increases with advancing age in both the gray matter and the white matter. In contrast to amyloid plaques and neurofibrillary tangles, there is no significant correlation between apoE genotype and density of microglia, although apoEepsilon4 homozygotes tended to have more microglia than did other apoE groups. In sections double-immunostained for Abeta and activated microglia, activated microglia were associated with dense-cored plaques but not with diffuse plaques, suggesting that microglial activation is a relatively late event in the genesis of beta-amyloid. Activation of microglia thus appears not to be the initial impetus for Abeta-deposition in the elderly.
- Published
- 2002
20. Grundlagen der Anatomie und Topographie in der Kopf-Halsregion
- Author
-
J. Pahnke
- Subjects
business.industry ,Medicine ,business - Published
- 2002
21. [MR tomography study of the development of the sphenoid sinus]
- Author
-
P, Zeitler, J, Pahnke, and S, Braitinger
- Subjects
Male ,Adolescent ,Sphenoid Sinus ,Cephalometry ,Reference Values ,Child, Preschool ,Humans ,Infant ,Female ,Child ,Magnetic Resonance Imaging ,Retrospective Studies - Abstract
Aim of this study was to evaluate the postnatal growth pattern of the sphenoid sinus.83 cerebral MRI examinations of infants and children aged 5 months to 14 years were retrospectively reviewed for pneumatization and growth of sphenoid sinus.A continuous increase of pneumatization and growth of the sphenoid sinus was demonstrated between infancy and adolescence including considerable individual variations. Even in children less than two years old remarkable spatial extends of this sinus could be found in some cases.Diagnosis of an acute or chronical sinusitis in pediatric patients should alert the clinician to the possibility of a sphenoidal participation.
- Published
- 2000
22. Interdisciplinary cooperative oncology for special head and neck malignancies
- Author
-
J, Helms, K, Schwager, F, Hoppe, J, Pahnke, V, Preissler, M, Flentje, L, Pfreundner, J, Richter, and W, Bohndorf
- Subjects
Male ,Patient Care Team ,Carcinoma, Squamous Cell ,Humans ,Female ,Mouth Neoplasms ,Neoplasms, Second Primary ,Combined Modality Therapy ,Laryngeal Neoplasms ,Ear Neoplasms ,Retrospective Studies - Published
- 2000
23. Acute visual loss by an Onodi cell
- Author
-
J Pahnke, W Lieb, T Klink, and F Hoppe
- Subjects
genetic structures ,business.industry ,Anatomy ,medicine.disease ,eye diseases ,Sensory Systems ,Optic neuropathy ,Cellular and Molecular Neuroscience ,Ophthalmology ,medicine.anatomical_structure ,Onodi cell ,Ethmoid sinus ,Optic nerve ,medicine ,Paranasal sinusitis ,Mucocele ,business ,Letters to the Editor ,Optic nerve diseases ,Sinus (anatomy) - Abstract
Editor,—In the literature Onodi cells occur in 3.4–51% of people.1 2 The paranasal sinus “Anatomic terminology group” defines the Onodi cell as the most posterior ethmoid cell which pneumatises laterally and superiorly to the sphenoid and is intimately associated with the optic nerve. Using this definition the incidence of Onodi cells is 8–14%.3-5 The occurrence of optic neuropathy caused by a pathological process in an Onodi cell is explained by the close relation to the optic nerve, because it often runs within the small cavity of the Onodi cell.6 Orbital inflammation associated with paranasal sinusitis is a well known cause of optic neuropathy,7 but an isolated mucocele of an Onodi cell causing optic neuropathy is rare.8 9 We report a case of acute visual loss caused by an isolated mucocele of an Onodi cell. ### CASE REPORT A 41 year old man was referred to our …
- Published
- 2000
24. [Long-term breathing via tracheostoma]
- Author
-
J, Pahnke, F, Bullemer, S, Heindl, B, Kroworsch, and O, Karg
- Subjects
Adult ,Aged, 80 and over ,Male ,Adolescent ,Middle Aged ,Long-Term Care ,Intermittent Positive-Pressure Ventilation ,Tracheostomy ,Child, Preschool ,Humans ,Female ,Child ,Intermittent Positive-Pressure Breathing ,Aged - Abstract
From 1988 to 2/1997 we had introduced intermittent positive pressure ventilation (IPPV) in 298 patients. In most cases non-invasive nasal mask ventilation was possible, in 21 patients (7%) a tracheostoma was necessary. These 21 patients were analysed retrospectively due to age, sex, diagnose, ventilation mode, course of illness, home care and costs.We had 13 male and 8 female patients, aged 49 years on average (min. 2, max. 84). 90% had neuromuscular diseases especially muscle dystrophies. Ventilation therapy was performed volume controlled with the cannula unblocked during daytime and blocked at night. Eighteen patients had industrial cannulas (72% Shiley, 28% Rüsch), 3 patients used silver cannulas. Daily ventilation amounted 24 hours in 7 patients, 6 to 14 hours in 14 patients. During the observed time 7 patients remained in stable health situation, in 9 patients the underlying disease was progressive and 5 of them died. IPPV was performed 50.7 months on an average, in living patients 68.8 months, in died 7.6 months. Fifteen patients lived at home, 5 were cared in nursing home, 1 patient stayed in hospital. Outside the hospital the bigger part of costs was paid by sick funds and care funds, the smaller part by social welfare offices. Often costs were divided. Total costs for caring about 24 hours ventilated patient at home amounted up to 21,000 German marks each month.
- Published
- 1999
25. [Systematic analysis of cervical lymph node metastasis of larynx and hypopharynx carcinomas--a clinical computerized tomography study with special reference to extension of the primary tumor]
- Author
-
L, Pfreundner, J, Pahnke, A, Desing, and M, Schindel
- Subjects
Adult ,Aged, 80 and over ,Male ,Hypopharyngeal Neoplasms ,Biopsy ,Middle Aged ,Lymphatic Metastasis ,Carcinoma, Squamous Cell ,Humans ,Female ,Neoplasm Invasiveness ,Lymph Nodes ,Tomography, X-Ray Computed ,Laryngeal Neoplasms ,Aged ,Neoplasm Staging ,Retrospective Studies - Abstract
To assess the incidence and patterns of cervical lymph node metastases in laryngeal and hypopharyngeal carcinomas according to the location, extension, and relation of the primary tumor to the parapharyngeal compartments and tissues arising from different embryological structures as branchial arches and somites.The findings of clinical and CT examinations of 230 patients with histological evidence of laryngeal and hypopharyngeal carcinoma (44 T1-, 33 T2-, 41 T3-, 112 T4-carcinomas with lymph node involvement in 116 cases) were evaluated retrospectively. Local tumor spread and relation of the primary to the parapharyngeal compartments and to tissues arising from different embryological structures such as branchial arches and somites were analysed and related to cervical lymph node involvement.The pattern of cervical lymph node involvement depends upon location and extension of the primary tumor in the adjacent tissues of the larynx and hypopharynx. The density of the lymphatic vessels in these areas determines the likelihood of lymph node involvement. The frequency of NO cases in carcinomas strictly located in the vocal cord (n = 31) was 100%; in the glottic-supraglottic, supraglottic, and transglottic cancer (n = 106) 85%; in larynx-hypopharynx carcinomas (n = 54) 26%; in hypopharynx carcinomas (n = 12) 17%; and in larynx-hypo-oropharynx carcinomas (n = 46) 9%. Tumors in tissues arising from branchial arches 4, 5, and 6 are glottic-supraglottic, transglottic laryngeal, and laryngeal-hypopharyngeal carcinomas. Metastases of these tumors were frequently found in the jugular lymph node chains, particularly if the developed tissue of the "primitive glottis" was invaded by the primary. Upper jugular nodes ipsilateral to a supraglottic or hypopharyngeal primary were usually involved. The frequency of metastases in the jugular lymph node chains decreased in craniocaudal direction. If the tumor invaded the posterior wall of the hypopharynx or tissues.
- Published
- 1996
26. [Advantages and disadvantages of invasive and noninvasive artificial respiration exemplified by a patient with postpolio syndrome]
- Author
-
J, Pahnke, F, Bullemer, and O, Karg
- Subjects
Treatment Outcome ,Humans ,Female ,Postpoliomyelitis Syndrome ,Middle Aged ,Respiratory Insufficiency ,Respiration, Artificial ,Ventilator Weaning ,Intermittent Positive-Pressure Breathing - Published
- 1996
27. [Noninvasive intermittent ventilation. A prospective data collection in patients with hypoventilation syndrome]
- Author
-
F, Bullemer, S, Heindl, J, Pahnke, and O, Karg
- Subjects
Adult ,Aged, 80 and over ,Male ,Adolescent ,Middle Aged ,Home Care Services ,Self Care ,Survival Rate ,Humans ,Female ,Prospective Studies ,Child ,Lung Volume Measurements ,Respiratory Insufficiency ,Intermittent Positive-Pressure Breathing ,Aged ,Follow-Up Studies - Abstract
Noninvasive intermittent ventilation is usually performed in patients with severe ventilatory pump disorder. From 1988 to 3/1995 we treated 163 patients with the aim of home mechanical ventilation (HMV).In March 1993 115 of these 163 patients practiced HMV, 22 had already died and 26 had rejected or broken off ventilation therapy. The 115 patients were classified in three main diagnostic groups: Scoliosis or chest wall disease (n = 76), COPD (n = 11) and neuromuscular disease (n = 28). The mean pCO2 at rest of all patients before ventilation therapy was 56 (+/- 12) Torr and fell to 46 (+/- 5) Torr in the course of therapy. The maximum statical inspiration pressure PImax rose from average 3, 8 (+/- 2, 3) to 4, 9 (+/- 2, 0) kPa. There was a probability of surviving two years after onset of ventilation therapy of 85% in the scoliosis group, of 60% in the neuromuscular group and of 30% in the COPD group.According to results of others home ventilation therapy was very successful in patients with chest wall disease. In some patients with neuromuscular disorder quality of life could be improved and life prolonged. Only half of the COPD patients could be treated successfully, whereas the other half had no benefit from noninvasive ventilation therapy.
- Published
- 1996
28. [Analysis of cervical lymph node metastasis of oropharyngeal carcinoma in relation to extent of the primary tumor]
- Author
-
L, Pfreundner, J, Pahnke, and S, Wameling
- Subjects
Adult ,Aged, 80 and over ,Male ,Oropharynx ,Radiotherapy Dosage ,Middle Aged ,Oropharyngeal Neoplasms ,Lymphatic Metastasis ,Carcinoma, Squamous Cell ,Humans ,Female ,Neoplasm Invasiveness ,Lymph Nodes ,Aged ,Neoplasm Staging ,Retrospective Studies - Abstract
To assess the incidence and patterns of cervical lymph node involvement according to the location and the relation of the primary tumour to the parapharyngeal fasciae, compartments and tissues arising from different branchial arches.The findings of clinical and CT examinations of 143 patients with histological evidence of oropharyngeal carcinoma were evaluated retrospectively. Local tumour spread, relation of the primary to the parapharyngeal fasciae, compartments and to the borders of tissues arising from different branchial arches were analysed and related to cervical lymph node involvement.Lymph drainage of the oropharynx and neighbouring neck regions is determined by the embryological development of the branchial arches and somites. Oropharyngeal carcinomas are tumours arising from tissues of the 2nd and 3rd branchial arches. The lymph of these tissues is collected by the vessels of the jugular neck node chains. If tumour invades tissues arising from the 1st branchial arch (structures of the oral cavity and floor of the mouth) tumour spreads into the ipsilateral lymphatic vessels arising from the 1st branchial arch and the submaxillary lymph nodes. If tumor invades tissues arising from occipital and cervical somites (posterior wall of the nasopharynx, retropharyngeal compartment and recessus submuscularis) metastases in the retropharyngeal and spinal-accessorial lymph nodes may appear. Regarding the tumour invasion of the subdistricts of the oropharynx totally different tumours were found. Tumour invasion of neighbouring structures was documented for the nasopharynx in 15%, for oral cavity and the floor of the mouth in 34%, the larynx in 24% and the hypopharynx in 22% of the cases. From these different patterns of local tumour spread different patterns of lymph node involvement resulted. Nodal involvement was found in 71%. In all these cases metastases in the ipsilateral upper jugular lymph nodes were present. The frequency of metastases in the jugular lymph node chains decreased in cranio-caudad direction (upper jugular group 100%, middle 18%, lower jugular group 5%). The frequency of bilateral jugular lymph node involvement (25%) increased in the some measure as the tumour approached the midline or crossed it.Knowledge of regular patterns of spread of oropharyngeal carcinoma is important for treatment procedures, especially for 3-dimensional radiotherapy.
- Published
- 1996
29. [BiPAP therapy of combined sleep related respiratory dysregulation in retrognathism and lymphatic hyperplasia]
- Author
-
J, Pahnke, K, Kruis, O, Karg, and R, Lund
- Subjects
Oxygen ,Positive-Pressure Respiration ,Sleep Apnea Syndromes ,Adolescent ,Tongue ,Castleman Disease ,Polysomnography ,Humans ,Female ,Retrognathia ,Respiratory Center ,Hypoxia - Published
- 1995
30. [Systemic fungal infections in hematologic neoplasms. An autopsy study of 1,053 patients]
- Author
-
B, Pfaffenbach, K, Donhuijsen, J, Pahnke, R, Bug, R J, Adamek, M, Wegener, and D, Ricken
- Subjects
Cross-Sectional Studies ,Leukemia ,Lymphoma ,Mycoses ,Bone Marrow ,Cause of Death ,Germany ,Incidence ,Humans ,Autopsy ,Opportunistic Infections ,Retrospective Studies - Abstract
Mycoses are common complications of haematological neoplasias. For successful antimycotic treatment, a knowledge of preferential underlying disease, frequency, species and site of the mycosis is of importance.Postmortem material comprising clinical data, autopsy protocols and histological sections obtained between 1976 and 1990 from 1,053 patients with leukaemia and malignant lymphomas following antineoplastic therapy was analysed retrospectively.Autopsy revealed systemic mycoses in 184 patients (17.5%). Between 1976 and 1990, the incidence of fungal infections increased from 12% to 30%, most being found in acute leukaemia (24%). Myeloproliferative syndrome (18%), non-Hodgkin's lymphomas (16%), Hodgkin's disease (10%) and plasmocytoma (2.5%) were less frequently associated with mycoses. With no preference for any particular malignancy in evidence, aspergillosis predominated at histology (85 cases), while candidosis occurred in 75 cases. A combination of two mycoses (aspergillosis and candidosis) (14 patients), zygomycosis (eight patients) and cryptococcosis (two patients) were much less common. While aspergillosis caused mostly pulmonary (81 cases) and cerebral (18 cases) infections, candidosis most frequently affected the GI tract (83 cases). The fungal infection was regarded as the main cause of death in some 76% of the cases. An analysis of bone marrow of patients with mycosis (184 cases) revealed a predominance of hypoplasia (54%) over tumour infiltration (34%) and normal bone marrow (12%). In malignancies with no mycoses (869 cases) in contrast, hypoplasia was significantly less common (19%) than infiltration (59%) or normal bone marrow (22%) (p0.001).The incidence of mycoses in haematological neoplasias in our post mortem series has continued to increase. Bone marrow hypoplasia in particular predisposes to fungal infection. The lungs are the organs of predilection, and aspergillosis is likely to be the infection presenting.
- Published
- 1994
31. Laserchirurgie mit Umlenkspiegeln
- Author
-
F. X. Brunner and J. Pahnke
- Abstract
Die Laserchirurgie hat sich in den letzten Jahren in mancher Hinsicht als eine echte Alternative zu konventionell-chirurgischen Techniken erwiesen und erbringt — entsprechende Erfahrung vorausgesetzt — beispielsweise in der Chirurgie der Papillomatosis des Larynx und der Trachea als kurative Masnahme bei umschriebener und palliativer Chirurgie bei ausgedehnten Malignomen gute Ergebnisse.
- Published
- 1994
32. HR-MR-Anatomie der Pars cartilaginea tubae auditivae
- Author
-
S. Braitinger and J. Pahnke
- Abstract
Ziel dieser Untersuchung ist es, die Strukturelemente der Pars cartilaginea tubae auditivae an hochaufgelosten Kernspintomogrammen zu identifizieren und nach Morphologie sowie Signalverhalten zu charakterisieren.
- Published
- 1994
33. Nase I: Klinik
- Author
-
B. Eistert, Jochen A. Werner, M. Eckstein, B. Furch, M. Honikel, G. Ricci, T. Klimek, P. Bumm, G. S. Godbersen, H. Marquardt, N. Bald, Simoncelli C, Chr. von Garrel, J. L. Scherrer, H. Lenders, Chr. Gammert, J. Pahnke, W. Bachmann, J. Lüttges, R. Füssle, Chr. Bannert, Molini E, and J. Kleeberg
- Abstract
Zur Therapie der Rhinitis sicca wird als Ersatz des fehlenden Nasensekretes das Zufuhren von Flussigkeiten oder Ersatzlosungen von ausen angewendet. Dabei sind bisher schon Losungen der verschiedensten Zusammensetzung benutzt worden. Deren gravierender Mangel ist, das der Feuchtigkeitsgewinn zu kurzfristig ist. Ursache dafur ist die kurze Haftzeit von Flussigkeiten auf Schleimhauten. Dies trifft auch fur Inhalationen zu. Bei den nasalen Schleimhauten kommt erschwerend hinzu, das der mucoziliare Transport fur einen schnellen Abtransport der Flussigkeit sorgt.
- Published
- 1993
34. Clinical Anatomy of the Sphenoidal Sinus
- Author
-
J. Lang and J. Pahnke
- Subjects
Paranasal sinuses ,medicine.anatomical_structure ,Sphenoidal sinus ,business.industry ,otorhinolaryngologic diseases ,Medicine ,Anatomy ,Surgical procedures ,business ,Clinical anatomy ,Sinus (anatomy) - Abstract
The sphenoidal sinus is an important space for surgical procedures. It is opened in inflammatory diseases of the paranasal sinuses, and the neurosurgeon passes through this sinus in order to reach the hypophyseal region. We report here some characteristics and new measurements of the sphenoidal sinus and hypophyseal region.
- Published
- 1991
35. Spectrometric Investigations of n-Heptane Preflame Reactions in a Motored Engine
- Author
-
A. J. Pahnke and K. J. Pipenberg
- Subjects
Heptane ,chemistry.chemical_compound ,Materials science ,chemistry ,General Engineering ,Analytical chemistry - Published
- 1957
36. [The sphenoid sinus, clinical anatomy of approaches to the pituitary region]
- Author
-
J, Lang, S, Bressel, and J, Pahnke
- Subjects
Male ,Sex Factors ,Sphenoid Sinus ,Pituitary Gland ,Humans ,Female ,Sella Turcica ,Functional Laterality - Abstract
Sphenoidal sinus, clinical anatomy: mean values of measurements and research. The ostium of the sinus is situated 4.8 mm paramedian, 4 mm behind the sphenoid sinus with a width of 13.8 mm. Conchal types were estimated in 3%, presellar types in 23.8%, sellar types in 28.6% and postsellar sinuses in 47.6%. The ostium of the sphenoid sinus has a distance to the anterior wall of the Sella turcica mean = 14.6 mm. Included are length values of the sinus, the prominences in the side wall, and the recessus. Our results are discussed with the results of earlier researchers.
- Published
- 1988
37. Design Factors Affecting the Performance of Exhaust Manifold Reactors
- Author
-
E. N. Cantwell and A. J. Pahnke
- Subjects
Exhaust manifold ,Waste management ,Mathematics - Published
- 1965
38. Effect of Combustion Chamber Deposits and Driving Conditions on Vehicle Exhaust Emissions
- Author
-
James F. Conte and Alden J. Pahnke
- Subjects
Waste management ,business.industry ,Environmental science ,Exhaust gas recirculation ,Combustion chamber ,business ,Secondary air injection ,Automotive engineering - Published
- 1969
39. Surface Ignition: Factors Affecting Its Occurrence In Engines
- Author
-
Alden J. Pahnke
- Subjects
Surface (mathematics) ,Ignition system ,Materials science ,law ,Composite material ,law.invention - Published
- 1963
40. Closure to 'Discussion of ‘Combustion of a Low-Volatility Fuel in a Turbojet Combustion Chamber—Effects of Fuel Vaporization’' (1953, Trans. ASME, 75, p. 1310)
- Author
-
V. V. Holmes, A. J. Pahnke, O. A. Uyehara, and P. S. Myers
- Published
- 1953
41. LITERATURE OF THE COMBUSTION OF PETROLEUM
- Author
-
E. L. d'Ouville, M. L. Kalinowski, CECIL E. BOORD, BERNARD LEWIS, GUENTHER VON ELBE, E. C. WOODWARD, JESSE S. BINFORD, ROBBIN C. ANDERSON, RALPH KLEIN, LOUIS J. SCHOEN, RICHARD B. MORRISON, THOMAS C. ADAMSON, ALEXANDER WEIR, WALTER ROTH, MILTON D. SCHEER, GILBERT S. BAHN, HENRY WISE, GEORGE A. AGOSTON, JAMES A. BROWNING, J. MASON PILCHER, RALPH E. THOMAS, FRANK E. BELLES, WENDELL P. HAWTHORNE, ERIC J. Y. SCOTT, A. J. PAHNKE, R. H. BLAKER, B. A. JONES, B. H. WEIL, M. H. GRAHAM, C. C. MIESSE, RICHARD J. MCCAFFERTY, ROBERT R. HIBBARD, MARTIN A. ELLIOTT, E. C. HUGHES, E. L. d'Ouville, M. L. Kalinowski, CECIL E. BOORD, BERNARD LEWIS, GUENTHER VON ELBE, E. C. WOODWARD, JESSE S. BINFORD, ROBBIN C. ANDERSON, RALPH KLEIN, LOUIS J. SCHOEN, RICHARD B. MORRISON, THOMAS C. ADAMSON, ALEXANDER WEIR, WALTER ROTH, MILTON D. SCHEER, GILBERT S. BAHN, HENRY WISE, GEORGE A. AGOSTON, JAMES A. BROWNING, J. MASON PILCHER, RALPH E. THOMAS, FRANK E. BELLES, WENDELL P. HAWTHORNE, ERIC J. Y. SCOTT, A. J. PAHNKE, R. H. BLAKER, B. A. JONES, B. H. WEIL, M. H. GRAHAM, C. C. MIESSE, RICHARD J. MCCAFFERTY, ROBERT R. HIBBARD, MARTIN A. ELLIOTT, and E. C. HUGHES
- Published
- 1958
42. First-in-human evaluation of 6-bromo-7-[ 11 C]methylpurine, a PET tracer for assessing the function of multidrug resistance-associated proteins in different tissues.
- Author
-
Mairinger S, Jackwerth M, Chalampalakis Z, Rausch I, Weber M, Wölfl-Duchek M, Pracher L, Nics L, Pahnke J, Langsteger W, Hacker M, Zeitlinger M, and Langer O
- Subjects
- Humans, Male, Female, Adult, Tissue Distribution, Middle Aged, Positron Emission Tomography Computed Tomography, Positron-Emission Tomography methods, Radiopharmaceuticals pharmacokinetics, Radioactive Tracers, Multidrug Resistance-Associated Proteins metabolism
- Abstract
Purpose: Multidrug resistance-associated protein 1 (MRP1) is a transport protein with a widespread tissue distribution, which has been implicated in the pathophysiology of Alzheimer's and chronic respiratory disease. PET with 6-bromo-7-[
11 C]methylpurine ([11 C]BMP) has been used to measure MRP1 function in rodents. In this study, [11 C]BMP was for the first time characterised in humans to assess the function of MRP1 and other MRP subtypes in different tissues., Methods: Thirteen healthy volunteers (7 men, 6 women) underwent dynamic whole-body PET scans on a long axial field-of-view (LAFOV) PET/CT system after intravenous injection of [11 C]BMP. Three subjects of each sex were scanned a second time to assess reproducibility. Volumes of interest were outlined for MRP-expressing tissues (cerebral cortex, cerebellum, choroid plexus, retina, lungs, myocardium, kidneys, and liver). From the time-activity curves, the elimination rate constant (kE , h- 1 ) was derived as a parameter for tissue MRP function and its test-retest variability (TRTV, %) was calculated. Radiation dosimetry was calculated using the Medical Internal Radiation Dose (MIRD) methodology., Results: Mean kE and corresponding TRTV values were: cerebral cortex: 0.055 ± 0.010 h- 1 (- 4 ± 24%), cerebellum: 0.033 ± 0.009 h- 1 (1 ± 39%), choroid plexus: 0.292 ± 0.059 h- 1 (0.1 ± 16%), retina: 0.234 ± 0.045 h- 1 (30 ± 38%), lungs: 0.875 ± 0.095 h- 1 (- 3 ± 11%), myocardium: 0.641 ± 0.105 h- 1 (11 ± 25%), kidneys: 1.378 ± 0.266 h- 1 (14 ± 16%), and liver: 0.685 ± 0.072 h- 1 (7 ± 9%). Significant sex differences were found for kE in the cerebellum, lungs and kidneys. Effective dose was 4.67 ± 0.18 µSv/MBq for men and 4.55 ± 0.18 µSv/MBq for women., Conclusion: LAFOV PET/CT with [11 C]BMP potentially allows for simultaneous assessment of MRP function in multiple human tissues. Mean TRTV of kE in different tissues was in an acceptable range, except for the retina. The radiation dosimetry of [11 C]BMP was in the typical range of11 C-tracers. LAFOV PET/CT holds great potential to assess at a whole-body, multi-tissue level molecular targets relevant for drug disposition in humans., Trial Registration: EudraCT 2021-006348-29. Registered 15 December 2021., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
43. Evaluation of cerebrospinal fluid (CSF) and interstitial fluid (ISF) mouse proteomes for the validation and description of Alzheimer's disease biomarkers.
- Author
-
Górska AM, Santos-García I, Eiriz I, Brüning T, Nyman T, and Pahnke J
- Subjects
- Animals, Mice, Proteomics methods, Disease Models, Animal, Microdialysis methods, Amyloid beta-Protein Precursor cerebrospinal fluid, Male, Alzheimer Disease cerebrospinal fluid, Biomarkers cerebrospinal fluid, Extracellular Fluid metabolism, Extracellular Fluid chemistry, Mice, Inbred C57BL, Proteome, Mice, Transgenic
- Abstract
Background: Mass spectrometry (MS)-based cerebrospinal fluid (CSF) proteomics is an important method for discovering biomarkers of neurodegenerative diseases. CSF serves as a reservoir for interstitial fluid (ISF), and extensive communication between the two fluid compartments helps to remove waste products from the brain., New Method: We performed proteomic analyses of both CSF and ISF fluid compartments using intracerebral microdialysis to validate and detect novel biomarkers of Alzheimer's disease (AD) in APPtg and C57Bl/6J control mice., Results: We identified up to 625 proteins in ISF and 4483 proteins in CSF samples. By comparing the biofluid profiles of APPtg and C57Bl/6J mice, we detected 37 and 108 significantly up- and downregulated candidates, respectively. In ISF, 7 highly regulated proteins, such as Gfap, Aldh1l1, Gstm1, and Txn, have already been implicated in AD progression, whereas in CSF, 9 out of 14 highly regulated proteins, such as Apba2, Syt12, Pgs1 and Vsnl1, have also been validated to be involved in AD pathogenesis. In addition, we also detected new interesting regulated proteins related to the control of synapses and neurotransmission (Kcna2, Cacng3, and Clcn6) whose roles as AD biomarkers should be further investigated., Comparison With Existing Methods: This newly established combined protocol provides better insight into the mutual communication between ISF and CSF as an analysis of tissue or CSF compartments alone., Conclusions: The use of multiple fluid compartments, ISF and CSF, for the detection of their biological communication enables better detection of new promising AD biomarkers., Competing Interests: Declaration of Competing Interest None., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
44. 25-Hydroxycholesterol attenuates tumor necrosis factor alpha-induced blood-brain barrier breakdown in vitro.
- Author
-
Loiola RA, Nguyen C, Dib S, Saint-Pol J, Dehouck L, Sevin E, Naudot M, Landry C, Pahnke J, Pot C, and Gosselet F
- Subjects
- Humans, Receptors, LDL metabolism, Receptors, LDL genetics, Signal Transduction drug effects, ATP Binding Cassette Transporter 1 metabolism, ATP Binding Cassette Transporter 1 genetics, Pericytes metabolism, Pericytes drug effects, Pericytes pathology, Hydroxymethylglutaryl CoA Reductases metabolism, Hydroxymethylglutaryl CoA Reductases genetics, Apolipoproteins E metabolism, Apolipoproteins E genetics, Liver X Receptors metabolism, Liver X Receptors genetics, Cells, Cultured, Hydroxycholesterols pharmacology, Hydroxycholesterols metabolism, Blood-Brain Barrier metabolism, Blood-Brain Barrier drug effects, Tumor Necrosis Factor-alpha metabolism, Tumor Necrosis Factor-alpha pharmacology, Sterol Regulatory Element Binding Protein 2 metabolism, Sterol Regulatory Element Binding Protein 2 genetics, Endothelial Cells metabolism, Endothelial Cells drug effects, Cholesterol metabolism
- Abstract
Intracellular cholesterol metabolism is regulated by the SREBP-2 and LXR signaling pathways. The effects of inflammation on these molecular mechanisms remain poorly studied, especially at the blood-brain barrier (BBB) level. Tumor necrosis factor α (TNFα) is a proinflammatory cytokine associated with BBB dysfunction. Therefore, the aim of our study was to investigate the effects of TNFα on BBB cholesterol metabolism, focusing on its underlying signaling pathways. Using a human in vitro BBB model composed of human brain-like endothelial cells (hBLECs) and brain pericytes (HBPs), we observed that TNFα increases BBB permeability by degrading the tight junction protein CLAUDIN-5 and activating stress signaling pathways in both cell types. TNFα also promotes cholesterol release and decreases cholesterol accumulation and APOE secretion. In hBLECs, the expression of SREBP-2 targets (LDLR and HMGCR) is increased, while ABCA1 expression is decreased. In HBPs, only LDLR and ABCA1 expression is increased. TNFα treatment also induces 25-hydroxycholesterol (25-HC) production, a cholesterol metabolite involved in the immune response and intracellular cholesterol metabolism. 25-HC pretreatment attenuates TNFα-induced BBB leakage and partially alleviates the effects of TNFα on ABCA1, LDLR, and HMGCR expression. Overall, our results suggest that TNFα favors cholesterol efflux via an LXR/ABCA1-independent mechanism at the BBB, while it activates the SREBP-2 pathway. Treatment with 25-HC partially reversed the effect of TNFα on the LXR/SREBP-2 pathways. Our study provides novel perspectives for better understanding cerebrovascular signaling events linked to BBB dysfunction and cholesterol metabolism in neuroinflammatory diseases., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
45. ABCC1 Is a ΔNp63 Target Gene Overexpressed in Squamous Cell Carcinoma.
- Author
-
La Banca V, De Domenico S, Nicolai S, Gatti V, Scalera S, Maugeri M, Mauriello A, Montanaro M, Pahnke J, Candi E, D'Amico S, and Peschiaroli A
- Subjects
- Humans, Animals, Mice, Cell Differentiation genetics, Mice, Knockout, Trans-Activators genetics, Trans-Activators metabolism, Cell Line, Tumor, Carcinoma, Squamous Cell genetics, Carcinoma, Squamous Cell metabolism, Carcinoma, Squamous Cell pathology, Multidrug Resistance-Associated Proteins genetics, Multidrug Resistance-Associated Proteins metabolism, Keratinocytes metabolism, Keratinocytes pathology, Transcription Factors genetics, Transcription Factors metabolism, Gene Expression Regulation, Neoplastic, Skin Neoplasms genetics, Skin Neoplasms pathology, Skin Neoplasms metabolism, Tumor Suppressor Proteins genetics, Tumor Suppressor Proteins metabolism, Cell Proliferation genetics
- Abstract
The transcription factor ΔNp63 plays a pivotal role in maintaining the integrity of stratified epithelial tissues by regulating the expression of distinct target genes involved in lineage specification, cell stemness, cell proliferation and differentiation. Here, we identified the ABC transporter subfamily member ABCC1 as a novel ΔNp63 target gene. We found that in immortalized human keratinocytes and in squamous cell carcinoma (SCC) cells, ∆Np63 induces the expression of ABCC1 by physically occupying a p63-binding site (p63 BS) located in the first intron of the ABCC1 gene locus. In cutaneous SCC and during the activation of the keratinocyte differentiation program, ∆Np63 and ABCC1 levels are positively correlated raising the possibility that ABCC1 might be involved in the regulation of the proliferative/differentiative capabilities of squamous tissue. However, we did not find any gross alteration in the structure and morphology of the epidermis in humanized hABCC1 knock-out mice. Conversely, we found that the genetic ablation of ABCC1 led to a marked reduction in inflammation-mediated proliferation of keratinocytes, suggesting that ABCC1 might be involved in the regulation of keratinocyte proliferation upon inflammatory/proliferative signals. In line with these observations, we found a significant increase in ABCC1 expression in squamous cell carcinomas (SCCs), a tumor type characterized by keratinocyte hyper-proliferation and a pro-inflammatory tumor microenvironment. Collectively, these data uncover ABCC1 as an additional ∆Np63 target gene potentially involved in those skin diseases characterized by dysregulation of proliferation/differentiation balance.
- Published
- 2024
- Full Text
- View/download PDF
46. Advancing 6-bromo-7-[ 11 C]methylpurine to clinical use: improved regioselective radiosynthesis, non-clinical toxicity data and human dosimetry estimates.
- Author
-
Mairinger S, Jackwerth M, Soukup O, Blaickner M, Decristoforo C, Nics L, Pahnke J, Hacker M, Zeitlinger M, and Langer O
- Abstract
Background: 6-Bromo-7-[
11 C]methylpurine ([11 C]BMP) is a radiotracer for positron emission tomography (PET) to measure multidrug resistance-associated protein 1 (MRP1) transport activity in different tissues. Previously reported radiosyntheses of [11 C]BMP afforded a mixture of 7- and 9-[11 C]methyl regioisomers. To prepare for clinical use, we here report an improved regioselective radiosynthesis of [11 C]BMP, the results of a non-clinical toxicity study as well as human dosimetry estimates based on mouse PET data., Results: [11 C]BMP was synthesised by regioselective N7 -methylation of 6-bromo-7H-purine (prepared under good manufacturing practice) with [11 C]methyl triflate in presence of 2,2,6,6-tetramethylpiperidine magnesium chloride in a TRACERlab™ FX2 C synthesis module. [11 C]BMP was obtained within a total synthesis time of approximately 43 min in a decay-corrected radiochemical yield of 20.5 ± 5.2%, based on starting [11 C]methyl iodide, with a radiochemical purity > 99% and a molar activity at end of synthesis of 197 ± 130 GBq/μmol (n = 28). An extended single-dose toxicity study conducted in male and female Wistar rats under good laboratory practice after single intravenous (i.v.) administration of unlabelled BMP (2 mg/kg body weight) revealed no test item related adverse effects. Human dosimetry estimates, based on dynamic whole-body PET data in female C57BL/6J mice, suggested that an i.v. injected activity amount of 400 MBq of [11 C]BMP will deliver an effective dose in the typical range of11 C-labelled radiotracers., Conclusions: [11 C]BMP can be produced in sufficient amounts and acceptable quality for clinical use. Data from the non-clinical safety evaluation showed no adverse effects and suggested that the administration of [11 C]BMP will be safe and well tolerated in humans., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
47. Emerging Role of ABC Transporters in Glia Cells in Health and Diseases of the Central Nervous System.
- Author
-
Villa M, Wu J, Hansen S, and Pahnke J
- Subjects
- Humans, Animals, Central Nervous System Diseases metabolism, Central Nervous System Diseases pathology, ATP-Binding Cassette Transporters metabolism, Neuroglia metabolism, Central Nervous System metabolism, Central Nervous System pathology
- Abstract
ATP-binding cassette (ABC) transporters play a crucial role for the efflux of a wide range of substrates across different cellular membranes. In the central nervous system (CNS), ABC transporters have recently gathered significant attention due to their pivotal involvement in brain physiology and neurodegenerative disorders, such as Alzheimer's disease (AD). Glial cells are fundamental for normal CNS function and engage with several ABC transporters in different ways. Here, we specifically highlight ABC transporters involved in the maintenance of brain homeostasis and their implications in its metabolic regulation. We also show new aspects related to ABC transporter function found in less recognized diseases, such as Huntington's disease (HD) and experimental autoimmune encephalomyelitis (EAE), as a model for multiple sclerosis (MS). Understanding both their impact on the physiological regulation of the CNS and their roles in brain diseases holds promise for uncovering new therapeutic options. Further investigations and preclinical studies are warranted to elucidate the complex interplay between glial ABC transporters and physiological brain functions, potentially leading to effective therapeutic interventions also for rare CNS disorders.
- Published
- 2024
- Full Text
- View/download PDF
48. Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition.
- Author
-
Misiachna A, Svobodova B, Netolicky J, Chvojkova M, Kleteckova L, Prchal L, Novak M, Hrabinova M, Kucera T, Muckova L, Moravcova Z, Karasova JZ, Pejchal J, Blazek F, Malinak D, Hakenova K, Krausova BH, Kolcheva M, Ladislav M, Korabecny J, Pahnke J, Vales K, Horak M, and Soukup O
- Subjects
- Humans, Receptors, N-Methyl-D-Aspartate, Tacrine chemistry, Cholinesterase Inhibitors chemistry, Binding Sites, Cholinesterases, Acetylcholinesterase metabolism, Neuroprotective Agents pharmacology, Neuroprotective Agents therapeutic use, Chemical and Drug Induced Liver Injury, Alzheimer Disease drug therapy, Piperidines
- Abstract
Tacrine (THA), a long withdrawn drug, is still a popular scaffold used in medicinal chemistry, mainly for its good reactivity and multi-targeted effect. However, THA-associated hepatotoxicity is still an issue and must be considered in drug discovery based on the THA scaffold. Following our previously identified hit compound 7-phenoxytacrine (7-PhO-THA), we systematically explored the chemical space with 30 novel derivatives, with a focus on low hepatotoxicity, anticholinesterase action, and antagonism at the GluN1/GluN2B subtype of the NMDA receptor. Applying the down-selection process based on in vitro and in vivo pharmacokinetic data, two candidates, I-52 and II-52, selective GluN1/GluN2B inhibitors thanks to the interaction with the ifenprodil-binding site, have entered in vivo pharmacodynamic studies. Finally, compound I-52, showing only minor affinity to AChE, was identified as a lead candidate with favorable behavioral and neuroprotective effects using open-field and prepulse inhibition tests, along with scopolamine-based behavioral and NMDA-induced hippocampal lesion models. Our data show that compound I-52 exhibits low toxicity often associated with NMDA receptor ligands, and low hepatotoxicity, often related to THA-based compounds., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
49. Performance and Sensitivity of [ 99m Tc]Tc-sestamibi Compared with Positron Emission Tomography Radiotracers to Measure P-glycoprotein Function in the Kidneys and Liver.
- Author
-
Hernández-Lozano I, Leterrier S, Mairinger S, Stanek J, Zacher AS, Breyer L, Hacker M, Zeitlinger M, Pahnke J, Tournier N, Wanek T, and Langer O
- Subjects
- Humans, Mice, Animals, Tomography, X-Ray Computed, ATP Binding Cassette Transporter, Subfamily B genetics, Positron-Emission Tomography methods, Radiopharmaceuticals, Liver diagnostic imaging, Tomography, Emission-Computed, Single-Photon, Kidney diagnostic imaging, Nitriles, Organotechnetium Compounds, Mice, Knockout, ATP Binding Cassette Transporter, Subfamily B, Member 1 genetics, Metoclopramide
- Abstract
P-glycoprotein (P-gp, encoded in humans by the ABCB1 gene and in rodents by the Abcb1a/b genes) is a membrane transporter that can restrict the intestinal absorption and tissue distribution of many drugs and may also contribute to renal and hepatobiliary drug excretion. The aim of this study was to compare the performance and sensitivity of currently available radiolabeled P-gp substrates for positron emission tomography (PET) with the single-photon emission computed tomography (SPECT) radiotracer [
99m Tc]Tc-sestamibi for measuring the P-gp function in the kidneys and liver. Wild-type, heterozygous ( Abcb1a/b(+/ - ) ), and homozygous ( Abcb1a/b( - / - ) ) Abcb1a/b knockout mice were used as models of different P-gp abundance in excretory organs. Animals underwent either dynamic PET scans after intravenous injection of [11 C] N -desmethyl-loperamide, ( R )-[11 C]verapamil, or [11 C]metoclopramide or consecutive static SPECT scans after intravenous injection of [99m Tc]Tc-sestamibi. P-gp in the kidneys and liver of the mouse models was analyzed with immunofluorescence labeling and Western blotting. In the kidneys, Abcb1a/b() mice had intermediate P-gp abundance compared with wild-type and Abcb1a/b(-/-) mice. Among the four tested radiotracers, renal clearance of radioactivity (CLurine,kidney ) was significantly reduced (-83%) in Abcb1a/b( - / - ) mice only for [99m Tc]Tc-sestamibi. Biliary clearance of radioactivity (CLbile,liver ) was significantly reduced in Abcb1a/b( - / - ) mice for [11 C] N -desmethyl-loperamide (-47%), [11 C]metoclopramide (-25%), and [99m Tc]Tc-sestamibi (-79%). However, in Abcb1a/b(+/ - ) mice, CLbile,liver was significantly reduced (-47%) only for [99m Tc]Tc-sestamibi. Among the tested radiotracers, [99m Tc]Tc-sestamibi performed best in measuring the P-gp function in the kidneys and liver. Owing to its widespread clinical availability, [99m Tc]Tc-sestamibi represents a promising probe substrate to assess systemic P-gp-mediated drug-drug interactions and to measure renal and hepatic P-gp function under different (patho-)physiological conditions.- Published
- 2024
- Full Text
- View/download PDF
50. Apolar Extracts of St. John's Wort Alleviate the Effects of β-Amyloid Toxicity in Early Alzheimer's Disease.
- Author
-
El Menuawy A, Brüning T, Eiriz I, Hähnel U, Marthe F, Möhle L, Górska AM, Santos-García I, Wangensteen H, Wu J, and Pahnke J
- Subjects
- Humans, Mice, Animals, Infant, Plant Extracts pharmacology, Plant Extracts therapeutic use, Plant Extracts chemistry, Phytotherapy, Silicon Dioxide therapeutic use, Amyloid beta-Peptides toxicity, Mice, Transgenic, Hypericum chemistry, Alzheimer Disease drug therapy, Alzheimer Disease chemically induced
- Abstract
Hypericum perforatum (St. John's wort) has been described to be beneficial for the treatment of Alzheimer's disease (AD). Different extractions have demonstrated efficiency in mice and humans, esp. extracts with a low hypericin and hyperforin content to reduce side effects such as phototoxicity. In order to systematically elucidate the therapeutic effects of H. perforatum extracts with different polarities, APP-transgenic mice were treated with a total ethanol extract (TE), a polar extract obtained from TE, and an apolar supercritical CO
2 (scCO2 ) extract. The scCO2 extract was formulated with silicon dioxide (SiO2 ) for better oral application. APP-transgenic mice were treated with several extracts (total, polar, apolar) at different concentrations. We established an early treatment paradigm from the age of 40 days until the age of 80 days, starting before the onset of cerebral β-amyloid (Aβ) deposition at 45 days of age. Their effects on intracerebral soluble and insoluble Aβ were analyzed using biochemical analyses. Our study confirms that the scCO2 H. perforatum formulation shows better biological activity against Aβ-related pathological effects than the TE or polar extracts. Clinically, the treatment resulted in a dose-dependent improvement in food intake with augmentation of the body weight, and, biochemically, it resulted in a significant reduction in both soluble and insoluble Aβ (-27% and -25%, respectively). We therefore recommend apolar H. perforatum extracts for the early oral treatment of patients with mild cognitive impairment or early AD.- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.